José Miguel Rivera‐Caravaca

Author

Instituto Murciano de Investigación Biosanitaria ORCID

Also Known As

A Tello-Montoliu, C Lopez-Garcia, F Marin, J M R C Rivera-Caravaca, J M R Caravaca, J M Rivera Caravaca, J M Rivera-Caravaca, J Rivera-Caravaca, J. Rivera-Caravaca, J.M Rivera-Caravaca

226

Publications

Citations

H-Index

Concepts

All Affiliations

Instituto Murciano de Investigación Biosanitaria Universidad de Murcia Centro de Investigación en Red en Enfermedades Cardiovasculares Aalborg University Hospital General Universitario Morales Meseguer

About

José Miguel Rivera‐Caravaca is an author at Instituto Murciano de Investigación Biosanitaria specializing in cardiovascular disease, cardiology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	447
2	Education	2	2	123
3	Health Sciences	2	2	109
4	Engineering	1	1	10
5	Nursing	1	1	75

José Miguel Rivera‐Caravaca

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
The COVID-19 Pandemic and Its Impact on Homebound Nursing Students Juana Inés Gallego‐Gómez, María Campillo-Cano, Aurora Carrión-Martínez, International Journal of Environmental Research and Public Health	2020	121
Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients José Miguel Rivera‐Caravaca, Vanessa Roldán, María Asunción Esteve‐Pastor, Thrombosis and Haemostasis Heart FailureImportant Risk FactorCerebrovascular DiseasePharmacotherapyOral Anticoagulation	2017	86
Effectiveness of music therapy and progressive muscle relaxation in reducing stress before exams and improving academic performance in Nursing students: A randomized trial Juana Inés Gallego‐Gómez, Serafín Balanza, Jesús Leal, Nurse Education Today MusicNursingExerciseProgressive Muscle RelaxationEducation	2019	75
MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation Ana B. Arroyo, Ascensión M. de los Reyes‐García, José Miguel Rivera‐Caravaca, Arteriosclerosis Thrombosis and Vascular Biology	2018	62
Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Alena Shantsila, Thrombosis and Haemostasis HypertensionModifiable Risk FactorsBleeding RiskLogistic AnalysisThrombosis	2017	61
Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores Vanessa Roldán, Vicente Vicente, Mariano Valdés, Thrombosis and Haemostasis	2017	60
Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores José Miguel Rivera‐Caravaca, Juan A. Vílchez, Josefa Gálvez, Stroke	2019	59
Relationship between sleep habits and academic performance in university Nursing students Juana Inés Gallego‐Gómez, María Teresa Rodríguez González-Moro, José Miguel Rodríguez González-Moro, BMC Nursing	2021	56
Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID‐19 José Miguel Rivera‐Caravaca, Iván J. Núñez‐Gil, David Vivas, European Journal of Clinical Investigation	2020	52
Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Inmaculada Roldán‐Rabadán, EP Europace	2017	48

Page 1